Study of Cavosonstat (N91115) in CF Patients Who Are Heterozygous for F508del-CFTR and a Gating Mutation and Being Treated With Ivacaftor

NCT02724527 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Cavosonstat
DRUG: Placebo

Sponsor

Nivalis Therapeutics, Inc.